Get started
Author

Qiang Zhang

ORCID: 0009-0008-2613-2155
Observed ORCID: 0009-0008-2613-2155
OpenAlex ID: A5037667616
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al. · Cancer Research · 234
A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy
2025 · Chengjunyu Zhang, Sen Liu, et al. · Research · 44
A stemness-based signature with inspiring indications in discriminating the prognosis, immune response, and somatic mutation of endometrial cancer patients revealed by machine learning
2024 · Xuecheng Pang, Yu Wang, et al. · Aging · 2
PDF
Supplementary Figures from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al. · 1
Data from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al. · 1
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma
2026 · Xuecheng Pang, Yu Wang, et al. · Discover Oncology
Supplementary Figures from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2025 · Ruihui Xie, Liang Cheng, et al.
Supplementary Materials and Methods from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2025 · Ruihui Xie, Liang Cheng, et al.
Supplementary Tables from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2025 · Ruihui Xie, Liang Cheng, et al.
Supplementary Tables from NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer
2024 · Ruihui Xie, Liang Cheng, et al.
Supplementary Figures from NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer
2024 · Ruihui Xie, Liang Cheng, et al.
Supplementary Materials and Methods from NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer
2024 · Ruihui Xie, Liang Cheng, et al.
Supplementary Figures from NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer
2024 · Ruihui Xie, Liang Cheng, et al.
Supplementary Tables from NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer
2024 · Ruihui Xie, Liang Cheng, et al.
Supplementary Materials and Methods from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al.
Supplementary Figures from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al.
Supplementary Tables from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al.
Supplementary Materials and Methods from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al.
Supplementary Tables from NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 · Ruihui Xie, Liang Cheng, et al.
Works count: 19
Citation count: 282
H-index: 2
I10-index: 2
Year
Topic
Type